CRISIL Expects Indian Pharma Sales To Climb 7%-9% In FY23
Due to challenges in export sales in the regulated markets and a large base effect in the home formulations sector, the Indian pharmaceutical industry...
Vaccine Cos Brace For Busy Months As Fear Of Influenza Looms
Flu season is just around the horizon as the summer draws to a close and fall looms. Influenza still poses a threat, and leading...
ViiV Sets Up A $500,000 Monkeypox Fund As Emergency Response
In a press statement, ViiV Healthcare stated that the Monkeypox Emergency Response Fund would be distributed to U.S. community-based organisations.
ViiV, which has a strong...
How The Pharmaceutical Sector Is Striving To Cut Emissions?
As competing businesses rushed to deliver the first COVID-19 vaccine starting in early 2020, the pharmaceutical sector has been in the press more than...
Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK
Adjupanrix, a pandemic influenza vaccine (split virion, inactivated, adjuvanted) manufactured by GSK, has been reserved for future manufacturing and supply under a framework agreement with...
NHS Lays Long COVID Action Plan For Many With Chronic Signs
Instead of having patients return to their GP office for a variety of tests, lengthy COVID specialist clinics will now be able to refer...
New Concept Allows Physical Partnering Event
Thanks to its novel real-cum-virtual Marketplace concept euroPLX 73 Vienna will be one of the first pharma partnering events, if not the first, to be...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...